RIME CFO awarded 233,791 stock options
Andre Alex reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Andre Alex reported acquisition or exercise transactions in this Form 4 filing.
Algorhythm Holdings, Inc. reported that its CFO & General Counsel, Andre Alex, received a grant of a non-qualified stock option covering 233,791 shares of common stock. The option was granted by the Board under the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan and was awarded at no cash cost to him on the grant date. These options vest and become exercisable in equal quarterly installments over four years, beginning on February 23, 2026, tying the award to continued service over the long term.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 233,791 | $0.00 | $0.00 |
Footnotes (2)
- F1. The reported transaction involved the Reporting Person's receipt of a non-qualified stock option to purchase 233,791 shares of the Issuer's common stock. The non-qualified stock option was granted by the Board of Directors of the Issuer. The options were granted pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan.
- F2. The shares subject to the non-qualified stock option shall vest and become exercisable in equal quarterly installments over a period of four (4) years commencing on February 23, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Algorhythm Holdings (RIME) disclose about Andre Alex in this Form 4?
How many Algorhythm Holdings (RIME) stock options were granted to Andre Alex?
When do the RIME stock options granted to Andre Alex start vesting?
Over what period do Andre Alex’s Algorhythm Holdings (RIME) options vest?
Under which plan were Andre Alex’s RIME stock options granted?
Did Andre Alex pay cash to receive the Algorhythm Holdings (RIME) option grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.